Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
18.8M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
3.05M
-
Shares change
-
+1.54M
-
Total reported value, excl. options
-
$11.4M
-
Value change
-
+$5.74M
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$3.72
Significant Holders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) as of Q1 2025
8 filings reported holding MDCX - Medicus Pharma Ltd. - Common shares, no par value as of Q1 2025.
Medicus Pharma Ltd. - Common shares, no par value (MDCX) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.05M shares
of 18.8M outstanding shares and own 16.27% of the company stock.
Largest 8 shareholders include Interchange Capital Partners, LLC (1.66M shares), ARMISTICE CAPITAL, LLC (1.27M shares), Private Advisor Group, LLC (56.8K shares), PATRIOT INVESTMENT MANAGEMENT GROUP, INC. (29.2K shares), UBS Group AG (21.3K shares), Base Wealth Management LLC (11.5K shares), OSAIC HOLDINGS, INC. (5K shares), and Royal Bank of Canada (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.